UK teams up with Singapore on healthtech regulation
A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
Newsletters and Deep Dive digital magazine
A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
Flow Neuroscience has secured FDA approval for FL-100, the first at-home brain stimulation device for major depressive disorder.
Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.
Agreement has been reached on the reform of EU pharma legislation, but industry thinks it does not go far enough to restore the bloc's global status.
Hims & Hers has launched its direct-to-consumer weight-loss therapy channel in the UK, offering Wegovy, Mounjaro, and OTC option Orlos.
Editor's Picks
Newsletters and Deep Dive
digital magazine